Showing results (161-170 of 173) with videos related to

Sort By:
Pageof 18
The New England Journal of Medicine|July 12, 2023
BRAF-MEK Inhibition in Newly Diagnosed Papillary CraniopharyngiomasPriscilla K Brastianos, Erin Twohy, Susan Geyer, et al.
Nature Communications|March 15, 2022
Phase 2 study of pembrolizumab in patients with recurrent and residual high-grade meningiomasPriscilla K Brastianos, Albert E Kim, Anita Giobbie-Hurder, et al.
Blood|March 18, 2021
A rapid genotyping panel for detection of primary central nervous system lymphomaMihir Gupta, Evan J Burns, Nicholas Z Georgantas, et al.
Neurosurgery|November 6, 2025
Use of an Expert Panel for Symptomatic Patients With Grade I Degenerative Lumbar Spondylolisthesis: A Randomized Clinical TrialZoher Ghogawala, Tasneem Z Rizvi, Zhibang Lin, et al.
Acta Neuropathologica Communications|January 16, 2015
Sporadic hemangioblastomas are characterized by cryptic VHL inactivationGanesh M Shankar, Amaro Taylor-Weiner, Nina Lelic, et al.
Blood|May 22, 2024
Rapid tumor DNA analysis of cerebrospinal fluid accelerates treatment of central nervous system lymphomaMihir Gupta, Joseph D Bradley, Elie Massaad, et al.
JAMA Oncology|July 17, 2015
Rapid Intraoperative Molecular Characterization of GliomaGanesh M Shankar, Joshua M Francis, Mikael L Rinne, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 8, 2018
Genotype-targeted local therapy of gliomaGanesh M Shankar, Ameya R Kirtane, Julie J Miller, et al.
Neuro-Oncology|June 28, 2025
Mesothelin is a surface antigen present on human meningioma and can be effectively targeted by CAR T-cellsRishab Ramapriyan, Fred G Barker, Leland G Richardson, et al.
Acta Neuropathologica|August 21, 2018
DMD genomic deletions characterize a subset of progressive/higher-grade meningiomas with poor outcomeTareq A Juratli, Devin McCabe, Naema Nayyar, et al.
Pageof 18